comparemela.com

Wall Street brokerages expect Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) to announce ($0.16) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have made estimates for Anavex Life Sciences’ earnings. Anavex Life Sciences posted earnings of ($0.14) per share during the same quarter last year, which indicates […]

Related Keywords

Athanasios Skarpelos ,Anavex Life Sciences Get Rating ,Northern Trust Corp ,Geode Capital Management ,Zacks Investment Research ,Blackrock Inc ,Anavex Life Sciences Corp ,Nasdaq ,Vanguard Group Inc ,Anavex Life Sciences ,Wall Street ,Get Rating ,Anavex Life Science ,Life Sciences ,Investment Research ,Anavex Life ,Director Athanasios Skarpelos ,Street Corp ,Capital Management ,Trust Corp ,Life Sciences Corp ,Nasdaq Avxl ,Avxl ,Medical ,Ratings ,Consensus ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.